Filana Therapeutics, Inc. (FLNA): Total Assets
$118.36M
As of 2025-12-31
$108.37M
As of 2026-03-31
-20.4%
3-year compound annual growth
+4.6%
5-year compound annual growth
+14.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $118.36M | -24.9% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $157.53M | +3.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $151.66M | -35.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $234.83M | -12.0% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $266.78M | +182.9% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $94.30M | +301.5% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $23.49M | +16.6% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $20.14M | +85.9% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $10.83M | -43.9% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $19.30M | -39.5% | 2018-02-06, Balance as of period end |
| 2015-12-31 | $31.92M | -22.0% | 2017-03-07, Balance as of period end |
| 2014-12-31 | $40.91M | -18.4% | 2016-03-03, Balance as of period end |
| 2013-12-31 | $50.10M | -11.9% | 2015-02-18, Balance as of period end |
| 2012-12-31 | $56.86M | -42.5% | 2014-02-05, Balance as of period end |
| 2011-12-31 | $98.96M | -0.2% | 2013-02-08, Balance as of period end |
| 2010-12-31 | $99.19M | n/a | 2012-02-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $118.36M | -24.9% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $117.18M | +51.2% |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $119.59M | -44.3% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $116.56M | -39.1% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $116.48M | -27.3% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $113.56M | +50.4% |
Compare FLNA, CAMP, AARD, KYNB side by side · Screen every company in Pharmaceutical Preparations ↗